Sutro Biopharma, Inc. (STRO) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist MOLINA ARTURO MD mit 37,500 Aktien. Weitere bedeutende Anteilseigner sind Freund John Gordon und NEWELL WILLIAM J.
In den letzten 12 Monaten haben Insider 44 Transaktionen in STRO Aktien getätigt — 28 Käufe (im Wert von $796.23K) und 0 Verkäufe (im Wert von RSU Award). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
STRO Insider-Beteiligungen
Größter Aktionär
MOLINA ARTURO MD
37,500 Aktien
Käufe (12 Monate)
28
$796.23K Wert
Verkäufe (12 Monate)
0
$0.00 Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Molina Arturo Md |
Chief Medical Officer |
37,500 |
2022-03-07 |
|
| 2 |
Freund John Gordon |
Director |
35,000 |
2024-06-10 |
|
| 3 |
Newell William J |
CEO |
31,125 |
2025-03-06 |
|
| 4 |
Worsley Stephen |
Chief Business Officer |
30,000 |
2019-01-31 |
|
| 5 |
Lawlis V Bryan |
Director |
26,033 |
2018-09-27 |
|
| 6 |
Sharp Shalini |
Director |
18,500 |
2022-06-08 |
|
| 7 |
Borgman Anne Elizabeth |
Chief Medical Officer |
17,812 |
2025-05-05 |
|
| 8 |
Shabbir Anik |
Chief Technical Ops. Officer |
17,500 |
2023-03-07 |
|
| 9 |
Leyman Barbara |
Chief Business Officer |
16,056 |
2025-08-26 |
|
| 10 |
Albini Edward C |
CFO and Secretary |
15,750 |
2025-03-04 |
|
| 11 |
Shtylla Brunilda |
Chief Business Officer |
12,928 |
2023-08-28 |
|
| 12 |
Janney Daniel |
Director |
11,610 |
2019-06-19 |
|
| 13 |
Fitzpatrick Linda A |
Chief People & Comm. Officer |
9,125 |
2025-03-06 |
|
| 14 |
Hallam Trevor |
Pres. Rsrch & Cf. Sctific Ofcr |
7,500 |
2023-04-17 |
|
| 15 |
Vasquez Nicki |
Chief Port. Strat & Alnce Ofcr |
6,500 |
2023-07-13 |
|
| 16 |
Srinivasan Venkatesh |
Chief Tech Op Officer |
5,000 |
2025-05-05 |
|
| 17 |
Chow Gregory K. |
CFO |
5,000 |
2026-03-03 |
|
| 18 |
Ross Michael Jay |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 19 |
Svlsf V, Llc |
10 Percent Owner |
4,315 |
2018-10-01 |
|
| 20 |
Gerber Hans-peter |
Chief Scientific Officer |
2,250 |
2026-03-03 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-04 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Optionsausübung (Verkauf) |
675 |
- |
- |
| 2026-03-04 |
Chung Jane |
Chief Executive Officer |
Optionsausübung (Verkauf) |
788 |
- |
- |
| 2026-03-02 |
Pauling David |
Chief Admin. Ofcr. & Gc |
RSU-Zuteilung |
4,200 |
- |
- |
| 2026-03-01 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Optionsausübung (Verkauf) |
500 |
- |
- |
| 2026-03-02 |
Gerber Hans-peter |
Chief Scientific Officer |
RSU-Zuteilung |
5,000 |
- |
- |
| 2026-03-01 |
Gerber Hans-peter |
Chief Scientific Officer |
Optionsausübung (Verkauf) |
1,125 |
- |
- |
| 2026-03-02 |
Chung Jane |
Chief Executive Officer |
RSU-Steuereinbehalt |
2,779 |
$20.55 |
$57.11K |
| 2026-03-01 |
Chung Jane |
Chief Executive Officer |
Optionsausübung (Verkauf) |
688 |
- |
- |
| 2026-03-02 |
Chow Gregory K. |
CFO |
RSU-Zuteilung |
5,000 |
- |
- |
| 2025-12-23 |
Pauling David |
Chief Admin. Ofcr. & Gc |
RSU-Zuteilung |
7,200 |
$10.38 |
$74.74K |
| 2025-12-23 |
Gerber Hans-peter |
Chief Scientific Officer |
RSU-Zuteilung |
7,925 |
$10.38 |
$82.26K |
| 2025-12-23 |
Hunter Heidi |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Chow Gregory K. |
CFO |
RSU-Zuteilung |
8,200 |
$10.38 |
$85.12K |
| 2025-12-23 |
Dybbs Michael |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Wigginton Jon Marc |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Jagpal Sukhi |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Lobacki Joseph M |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Petree Daniel H |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Matsui Connie |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-23 |
Panek James P |
Director |
RSU-Zuteilung |
1,500 |
$10.38 |
$15.57K |
| 2025-12-12 |
Chung Jane |
Chief Executive Officer |
Optionsausübung (Verkauf) |
2,500 |
- |
- |
| 2025-10-15 |
Pauling David |
Chief Admin. Ofcr. & Gc |
Informierter Kauf |
12,504 |
$0.80 |
$9.99K |
| 2025-10-15 |
Gerber Hans-peter |
Chief Scientific Officer |
Informierter Kauf |
17,000 |
$0.80 |
$13.61K |
| 2025-10-15 |
Chung Jane |
Chief Executive Officer |
Informierter Kauf |
12,500 |
$0.80 |
$10.01K |
| 2025-10-15 |
Chow Gregory K. |
CFO |
Informierter Kauf |
19,750 |
$0.81 |
$16K |
